$BNGO “While Bionano reported $2.2 million in Q3 2020 revenue, slightly ahead of consensus expectations for $2.1 million, it represented a 33% decline year over year. Profits-wise, Bionano reported a $10.8 million net loss (up 69% year over year) as a result of increased research and development spending, and a near-doubling in selling, general, and administrative expenses. Despite the disappointing reaction among investors, two Wall Street investment banks stepped in to reiterate their support of the stock, and to predict that Bionano stock will not only recover its losses, but grow three times in value over the next year... or maybe even four times.”
  • 8